Trademark Overview

---

On Wednesday, December 19, 2001, a trademark application was filed for ARVITAMAB with the United States Patent and Trademark Office. The USPTO has given the ARVITAMAB trademark a serial number of 76350291. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 21, 2012. This trademark is owned by Arius Research Inc.. The ARVITAMAB trademark is filed in the Pharmaceutical Products category with the following description:

antibodies used in the treatment of cancer

General Information

---

Serial Number	76350291
Word Mark	ARVITAMAB
Filing Date	Wednesday, December 19, 2001
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, September 21, 2012
Registration Number	3051992
Registration Date	Tuesday, January 31, 2006
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, January 4, 2005

Trademark Statements

---

Goods and Services

antibodies used in the treatment of cancer

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, September 21, 2012
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	Arius Research Inc.
Party Type	30 - Original Registrant
Legal Entity Type	03 - Corporation
Address	Toronto, Ontario M5J 1R7 CA

---

Party Name	Arius Research Inc.
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	Toronto, Ontario M5J 1R7 CA

---

Party Name	Arius Research Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Toronto, Ontario M5J 1R7 CA

Trademark Events

---

Event Date	Event Description
Friday, September 21, 2012	CANCELLED SEC. 8 (6-YR)
Tuesday, January 31, 2006	REGISTERED-PRINCIPAL REGISTER
Monday, December 12, 2005	1(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, September 29, 2005	NOTICE OF ALLOWANCE CANCELLED
Saturday, June 18, 2005	TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 7, 2005	CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 7, 2005	TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 29, 2005	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 4, 2005	PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2004	NOTICE OF PUBLICATION
Friday, October 29, 2004	LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 22, 2004	ASSIGNED TO LIE
Tuesday, October 19, 2004	APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2004	AMENDMENT FROM APPLICANT ENTERED
Thursday, September 30, 2004	CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 30, 2004	PAPER RECEIVED
Monday, May 10, 2004	INQUIRY AS TO SUSPENSION MAILED
Monday, March 15, 2004	PAPER RECEIVED
Monday, September 15, 2003	LETTER OF SUSPENSION MAILED
Thursday, June 26, 2003	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 1, 2003	CASE FILE IN TICRS
Thursday, June 26, 2003	PAPER RECEIVED
Thursday, May 29, 2003	LETTER OF SUSPENSION MAILED
Monday, March 17, 2003	CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2003	INQUIRY AS TO SUSPENSION MAILED
Monday, March 17, 2003	PAPER RECEIVED
Friday, August 16, 2002	LETTER OF SUSPENSION MAILED
Monday, June 24, 2002	CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 24, 2002	PAPER RECEIVED
Tuesday, March 12, 2002	NON-FINAL ACTION MAILED
Thursday, March 7, 2002	ASSIGNED TO EXAMINER

Related Keywords

---

arvitamab cancer treatment used antibodies